Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 421

1.

Structured Monolithic Catalysts vs. Fixed Bed for the Oxidative Dehydrogenation of Propane.

Rossetti I, Bahadori E, Tripodi A, Ramis G.

Materials (Basel). 2019 Mar 16;12(6). pii: E884. doi: 10.3390/ma12060884.

2.

Characterizing bumble bee (Bombus) communities in the United States and assessing a conservation monitoring method.

Strange JP, Tripodi AD.

Ecol Evol. 2019 Jan 13;9(3):1061-1069. doi: 10.1002/ece3.4783. eCollection 2019 Feb.

3.

Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.

Intagliata NM, Caldwell SH, Tripodi A.

Gastroenterology. 2019 Feb 13. pii: S0016-5085(19)30372-5. doi: 10.1053/j.gastro.2019.01.265. [Epub ahead of print] Review.

PMID:
30771355
4.

Position paper on laboratory testing for patients with haemophilia. A consensus document from SISET, AICE, SIBioC and SIPMeL.

Tripodi A, Santoro RC, Testa S, Molinari AC, Bernardini S, Golato M, Lippi G, Ageno W, Santagostino E.

Blood Transfus. 2019 Feb 4:1-7. doi: 10.2450/2019.0241-18. [Epub ahead of print] No abstract available.

5.

Body mass index reduction improves the baseline procoagulant imbalance of obese subjects.

Tripodi A, Primignani M, Badiali S, de Ruberto F, Granelli P, Tosetti G, Clerici M, Padovan L, Chantarangkul V, Scalambrino E, Peyvandi F.

J Thromb Thrombolysis. 2019 Jan 30. doi: 10.1007/s11239-019-01818-9. [Epub ahead of print]

PMID:
30701462
6.

An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays.

Cini M, Legnani C, Testa S, Tripodi A, Cosmi B, Palareti G.

Int J Lab Hematol. 2019 Jan 30. doi: 10.1111/ijlh.12974. [Epub ahead of print]

PMID:
30698331
7.

Thrombin generation assay for testing hemostatic effect of factor VIII concentrates in patients with hemophilia A and inhibitors: In vitro results from the PredicTGA study.

Tripodi A, Chantarangkul V, Clerici M, Bader R, Anzoletti MB, Peyvandi F, Santagostino EM; PredicTGA Collaborators.

Thromb Res. 2019 Feb;174:84-87. doi: 10.1016/j.thromres.2018.12.007. Epub 2018 Dec 6. No abstract available.

PMID:
30579150
8.

Requirement of a reference measurement system for the tissue factor-induced coagulation time and the international normalized ratio.

van den Besselaar AMHP, van Rijn CJJ, Hubbard AR, Kitchen S, Tripodi A, Cobbaert CM.

Clin Chem Lab Med. 2018 Dec 4. pii: /j/cclm.ahead-of-print/cclm-2018-1194/cclm-2018-1194.xml. doi: 10.1515/cclm-2018-1194. [Epub ahead of print] No abstract available.

PMID:
30511926
9.

Thromboelastometry. Reproducibility of duplicate measurement performed by the RoTem® device.

Scalambrino E, Padovan L, Clerici M, Chantarangkul V, Biliou S, Peyvandi F, Tripodi A.

Thromb Res. 2018 Dec;172:139-141. doi: 10.1016/j.thromres.2018.10.030. Epub 2018 Oct 31. No abstract available.

PMID:
30412836
10.

The intra-assay reproducibility of thromboelastography in very low birth weight infants.

Ghirardello S, Raffaeli G, Scalambrino E, Chantarangkul V, Cavallaro G, Artoni A, Mosca F, Tripodi A.

Early Hum Dev. 2018 Dec;127:48-52. doi: 10.1016/j.earlhumdev.2018.10.004. Epub 2018 Oct 9.

PMID:
30312859
11.

Advances in the Treatment of Hemophilia: Implications for Laboratory Testing.

Tripodi A, Chantarangkul V, Novembrino C, Peyvandi F.

Clin Chem. 2019 Feb;65(2):254-262. doi: 10.1373/clinchem.2017.284356. Epub 2018 Oct 3. Review.

PMID:
30282700
12.

Full Sternotomy, Hemisternotomy, and Minithoracotomy for Aortic Valve Surgery: Is There a Difference?

Mikus E, Calvi S, Campo G, Pavasini R, Paris M, Raviola E, Panzavolta M, Tripodi A, Ferrari R, Del Giglio M.

Ann Thorac Surg. 2018 Dec;106(6):1782-1788. doi: 10.1016/j.athoracsur.2018.07.019. Epub 2018 Sep 1.

PMID:
30179623
13.

How and when to measure anticoagulant effects of direct oral anticoagulants? Practical issues.

Tripodi A, Braham S, Scimeca B, Moia M, Peyvandi F.

Pol Arch Intern Med. 2018 Jun 29;128(6):379-385. doi: 10.20452/pamw.4287. Epub 2018 Jun 29.

14.

Direct oral anticoagulants and cirrhosis: More evidence still needed for efficacy and safety in portal vein thrombosis.

Mannucci PM, Tripodi A.

Vascul Pharmacol. 2019 Feb;113:92-93. doi: 10.1016/j.vph.2018.06.005. Epub 2018 Jun 8. Review. No abstract available.

PMID:
29890295
15.

A Nonlethal Method to Examine Non-Apis Bees for Mark-Capture Research.

Boyle NK, Tripodi AD, Machtley SA, Strange JP, Pitts-Singer TL, Hagler JR.

J Insect Sci. 2018 May 1;18(3). doi: 10.1093/jisesa/iey043.

16.

Development of novel cyclic NGR peptide-daunomycin conjugates with dual targeting property.

Tripodi AAP, Tóth S, Enyedi KN, Schlosser G, Szakács G, Mező G.

Beilstein J Org Chem. 2018 Apr 25;14:911-918. doi: 10.3762/bjoc.14.78. eCollection 2018.

17.

Right anterior mini-thoracotomy vs. conventional sternotomy for aortic valve replacement: a propensity-matched comparison.

Del Giglio M, Mikus E, Nerla R, Micari A, Calvi S, Tripodi A, Campo G, Maietti E, Castriota F, Cremonesi A.

J Thorac Dis. 2018 Mar;10(3):1588-1595. doi: 10.21037/jtd.2018.03.47.

18.

The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures.

Tripodi A, Marongiu F, Moia M, Palareti G, Pengo V, Poli D, Prisco D, Testa S, Zanazzi M.

Intern Emerg Med. 2018 Oct;13(7):1029-1036. doi: 10.1007/s11739-018-1854-6. Epub 2018 Apr 26. Review.

PMID:
29700696
19.

Novel multiplex PCR reveals multiple trypanosomatid species infecting North American bumble bees (Hymenoptera: Apidae: Bombus).

Tripodi AD, Szalanski AL, Strange JP.

J Invertebr Pathol. 2018 Mar;153:147-155. doi: 10.1016/j.jip.2018.03.009. Epub 2018 Mar 14.

PMID:
29550403
20.

Mapping Potential Amplification and Transmission Hotspots for MERS-CoV, Kenya.

Gikonyo S, Kimani T, Matere J, Kimutai J, Kiambi SG, Bitek AO, Juma Ngeiywa KJZ, Makonnen YJ, Tripodi A, Morzaria S, Lubroth J, Rugalema G, Fasina FO.

Ecohealth. 2018 Jun;15(2):372-387. doi: 10.1007/s10393-018-1317-6. Epub 2018 Mar 16.

PMID:
29549589
21.
22.

Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants.

Testa S, Paoletti O, Legnani C, Dellanoce C, Antonucci E, Cosmi B, Pengo V, Poli D, Morandini R, Testa R, Tripodi A, Palareti G.

J Thromb Haemost. 2018 May;16(5):842-848. doi: 10.1111/jth.14001. Epub 2018 Apr 17.

PMID:
29532628
23.

Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban.

Martinelli I, Abbattista M, Bucciarelli P, Tripodi A, Artoni A, Gianniello F, Novembrino C, Peyvandi F.

Haematologica. 2018 Jul;103(7):e315-e317. doi: 10.3324/haematol.2017.185132. Epub 2018 Mar 8. No abstract available.

24.

Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme.

Tripodi A, Chantarangkul V, Legnani C, Testa S, Tosetto A.

J Thromb Haemost. 2018 Mar;16(3):565-570. doi: 10.1111/jth.13949. Epub 2018 Jan 29.

PMID:
29322630
25.

The Value Chain Approach in One Health: Conceptual Framing and Focus on Present Applications and Challenges.

Antoine-Moussiaux N, Peyre M, Bonnet P, Bebay C, Bengoumi M, Tripodi A.

Front Vet Sci. 2017 Dec 11;4:206. doi: 10.3389/fvets.2017.00206. eCollection 2017.

26.

Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register.

Cini M, Legnani C, Cosmi B, Testa S, Dellanoce C, Paoletti O, Marcucci R, Poli D, Paniccia R, Pengo V, Tripodi A, Palareti G; START-Laboratory Register.

Int J Lab Hematol. 2018 Apr;40(2):229-236. doi: 10.1111/ijlh.12772. Epub 2018 Jan 3.

PMID:
29314632
27.

Response to Portal vein thrombosis after hepatitis C eradication with direct acting antiviral therapy.

Tripodi A.

Liver Int. 2018 Jan;38(1):186. doi: 10.1111/liv.13582. No abstract available.

PMID:
29272568
28.

Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL.

Tripodi A, Ageno W, Ciaccio M, Legnani C, Lippi G, Manotti C, Marcucci R, Moia M, Morelli B, Poli D, Steffan A, Testa S.

Blood Transfus. 2018 Sep;16(5):462-470. doi: 10.2450/2017.0124-17. Epub 2017 Sep 13.

29.

Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2 DS2 VASc 1 or 2): A treatment dilemma.

Denas G, Zoppellaro G, Padayattil Jose S, Antonucci E, Marongiu F, Poli D, Testa S, Tripodi A, Palareti G, Pengo V.

Cardiovasc Ther. 2018 Feb;36(1). doi: 10.1111/1755-5922.12310. Epub 2017 Nov 11.

PMID:
29078033
30.

Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.

La Mura V, Braham S, Tosetti G, Branchi F, Bitto N, Moia M, Fracanzani AL, Colombo M, Tripodi A, Primignani M.

Clin Gastroenterol Hepatol. 2018 Jul;16(7):1146-1152.e4. doi: 10.1016/j.cgh.2017.10.016. Epub 2017 Oct 21.

PMID:
29066371
31.

International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain.

van den Besselaar AMHP, Chantarangkul V, Angeloni F, Binder NB, Byrne M, Dauer R, Gudmundsdottir BR, Jespersen J, Kitchen S, Legnani C, Lindahl TL, Manning RA, Martinuzzo M, Panes O, Pengo V, Riddell A, Subramanian S, Szederjesi A, Tantanate C, Herbel P, Tripodi A.

J Thromb Haemost. 2018 Jan;16(1):142-149. doi: 10.1111/jth.13879. Epub 2017 Dec 1.

PMID:
29065247
32.

A Stakeholder Survey on Live Bird Market Closures Policy for Controlling Highly Pathogenic Avian Influenza in Vietnam.

Nguyen TTT, Fearnley L, Dinh XT, Tran TTA, Tran TT, Nguyen VT, Tago D, Padungtod P, Newman SH, Tripodi A.

Front Vet Sci. 2017 Aug 22;4:136. doi: 10.3389/fvets.2017.00136. eCollection 2017.

33.

Commentary.

Tripodi A.

Clin Chem. 2017 Sep;63(9):1445-1446. doi: 10.1373/clinchem.2017.272054. No abstract available.

34.

Lupus Anticoagulant Testing: Activated Partial Thromboplastin Time (APTT) and Silica Clotting Time (SCT).

Tripodi A, Chantarangkul V.

Methods Mol Biol. 2017;1646:177-183. doi: 10.1007/978-1-4939-7196-1_15.

PMID:
28804829
35.

The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment.

Tripodi A.

J Thromb Haemost. 2017 Sep;15(9):1882-1883. doi: 10.1111/jth.13750. Epub 2017 Jul 14. No abstract available.

PMID:
28585328
36.

Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago.

Palareti G, Antonucci E, Migliaccio L, Erba N, Marongiu F, Pengo V, Poli D, Testa S, Tosetto A, Tripodi A, Moia M; centers participating in the FCSA-START-Register (The ISCOAT 2016 study: Italian Study on Complications of Oral Anticoagulant Therapy-2016).

Intern Emerg Med. 2017 Dec;12(8):1109-1119. doi: 10.1007/s11739-017-1678-9. Epub 2017 May 13.

37.

Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.

Tripodi A, Chantarangkul V, Cini M, Devreese K, Dlott JS, Giacomello R, Gray E, Legnani C, Martinuzzo ME, Pradella P, Siegemund A, Subramanian S, Suchon P, Testa S.

J Thromb Haemost. 2017 Jun;15(6):1180-1190. doi: 10.1111/jth.13678. Epub 2017 Apr 18.

PMID:
28316135
38.

Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.

Tripodi A.

Thromb Haemost. 2017 May 3;117(5):830-836. doi: 10.1160/TH16-10-0806. Epub 2017 Feb 23. Review.

PMID:
28229158
39.

Hemostasis in Acute and Chronic Liver Disease.

Tripodi A.

Semin Liver Dis. 2017 Feb;37(1):28-32. doi: 10.1055/s-0036-1597770. Epub 2017 Feb 15. Review.

40.

Evaluation of coagulation during treatment with directly acting antivirals in patients with hepatitis C virus related cirrhosis.

Tripodi A, D'Ambrosio R, Padovan L, Tosetti G, Aghemo A, Primignani M, Chantarangkul V, Peyvandi F, Colombo M.

Liver Int. 2017 Sep;37(9):1295-1303. doi: 10.1111/liv.13374. Epub 2017 Feb 23.

PMID:
28129465
41.

Critical laboratory values in hemostasis: toward consensus.

Lippi G, Adcock D, Simundic AM, Tripodi A, Favaloro EJ.

Ann Med. 2017 Sep;49(6):455-461. doi: 10.1080/07853890.2016.1278303. Epub 2017 Feb 10. Review.

PMID:
28042729
42.

To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply.

Tripodi A.

J Thromb Haemost. 2017 Jan;15(1):202-204. doi: 10.1111/jth.13572. Epub 2017 Jan 13. No abstract available.

43.

Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH.

Tripodi A, de Laat B, Wahl D, Ageno W, Cosmi B, Crowther M; Subcommittees on Control of Anticoagulation and Lupus Anticoagulant/Antiphospholipid Antibodies.

J Thromb Haemost. 2016 Nov;14(11):2304-2307. doi: 10.1111/jth.13481. Epub 2016 Nov 7. No abstract available.

44.

Changing Concepts of Cirrhotic Coagulopathy.

Tripodi A, Primignani M, Mannucci PM, Caldwell SH.

Am J Gastroenterol. 2017 Feb;112(2):274-281. doi: 10.1038/ajg.2016.498. Epub 2016 Nov 1. Review.

PMID:
27801884
45.

To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply.

Tripodi A.

J Thromb Haemost. 2016 Dec;14(12):2559-2561. doi: 10.1111/jth.13513. Epub 2016 Oct 24. No abstract available.

46.

Procoagulant imbalance in patients with non-alcoholic fatty liver disease.

Tripodi A, Fracanzani AL, Chantarangkul V, Primignani M, Fargion S.

J Hepatol. 2017 Jan;66(1):248-250. doi: 10.1016/j.jhep.2016.09.025. Epub 2016 Oct 18. No abstract available.

PMID:
27769731
47.

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.

Testa S, Legnani C, Tripodi A, Paoletti O, Pengo V, Abbate R, Bassi L, Carraro P, Cini M, Paniccia R, Poli D, Palareti G.

J Thromb Haemost. 2016 Nov;14(11):2194-2201. doi: 10.1111/jth.13486. Epub 2016 Oct 15.

48.

Extracellular vesicle-driven information mediates the long-term effects of particulate matter exposure on coagulation and inflammation pathways.

Pavanello S, Bonzini M, Angelici L, Motta V, Pergoli L, Hoxha M, Cantone L, Pesatori AC, Apostoli P, Tripodi A, Baccarelli A, Bollati V.

Toxicol Lett. 2016 Sep 30;259:143-150. doi: 10.1016/j.toxlet.2016.08.002. Epub 2016 Aug 6.

PMID:
27506416
49.

Coagulation parameters in patients with cirrhosis and portal vein thrombosis treated sequentially with low molecular weight heparin and vitamin K antagonists.

Tripodi A, Primignani M, Braham S, Chantarangkul V, Clerici M, Moia M, Peyvandi F.

Dig Liver Dis. 2016 Oct;48(10):1208-13. doi: 10.1016/j.dld.2016.06.027. Epub 2016 Jul 1.

PMID:
27470055
50.

Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors.

Tripodi A, Ammollo CT, Semeraro F, Colucci M, Malchiodi E, Verrua E, Ferrante E, Arnaldi G, Trementino L, Padovan L, Chantarangkul V, Peyvandi F, Mantovani G.

Endocrine. 2017 May;56(2):298-307. doi: 10.1007/s12020-016-1027-1. Epub 2016 Jul 22.

PMID:
27448294

Supplemental Content

Loading ...
Support Center